These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 13312268)

  • 21. [Intravenous therapy of diseases of the liver parenchyma with liver hydrolysates].
    NOELLE R
    Dtsch Med Wochenschr; 1953 Sep; 78(39):1331-40. PubMed ID: 13095073
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of treatment with a protein-free liver extract].
    GUTEWA J
    Praxis; 1962 Apr; 51():444-9. PubMed ID: 13903140
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the therapy of chronic liver diseases with raw liver extract].
    KRENTZ K
    Gastroenterologia; 1960; 93():300-22. PubMed ID: 14411938
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current problems in the treatment of hepatic cirrhosis].
    Oancea R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):303-10. PubMed ID: 6173910
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF
    Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
    [No Abstract]   [Full Text] [Related]  

  • 26. Cirrhosis of the liver with special reference to intravenous liver extract therapy.
    AKBARALI ; MEHROTRA RP; ARORA MM; MUKERJI DP
    J Indian Med Assoc; 1961 Jan; 36():7-13. PubMed ID: 13681892
    [No Abstract]   [Full Text] [Related]  

  • 27. [Trial of LL 650 in various hepatic diseases].
    Savoye B; Dietsch R; Chapuy M; Girard M
    J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113
    [No Abstract]   [Full Text] [Related]  

  • 28. [Control of blood proteins in chronic liver diseases by treatment with liver hydrolysates].
    JOBST H
    Med Klin; 1956 Apr; 51(14):600-5. PubMed ID: 13333596
    [No Abstract]   [Full Text] [Related]  

  • 29. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic action of an enzymatic liver extract in hepatic pathology].
    GAJDOS D
    Gaz Med Fr; 1962 Feb; 69():499-505. PubMed ID: 13896275
    [No Abstract]   [Full Text] [Related]  

  • 31. Sirepar in the treatment of hepatic cirrhosis and its effect on autoantibody levels.
    Fassati P; Fassati M; Horejsí J; Jezková Z
    Tijdschr Gastroenterol; 1974; 17(4):259-66. PubMed ID: 4462729
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of alcoholic cirrhosis].
    ALAGILLE D
    Vie Med; 1953 Aug; 34(8):721-6. PubMed ID: 13122948
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases].
    Kleine FD
    Z Arztl Fortbild (Jena); 1966 Aug; 60(15):900-4. PubMed ID: 5995281
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis].
    Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D
    Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of chronic liver diseases with a special reference to liver hydrolysate].
    KRAUSE M
    Z Arztl Fortbild (Jena); 1955 May; 49(9):289-93. PubMed ID: 14397537
    [No Abstract]   [Full Text] [Related]  

  • 36. [Perorally effective liver extract in therapy of chronic liver parenchymal diseases].
    JASINSKI B
    Schweiz Med Wochenschr; 1957 Feb; 87(6):144-7. PubMed ID: 13421634
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepason in the treatment of hepatocellular diseases].
    Stazka Z; Korolko A
    Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
    [No Abstract]   [Full Text] [Related]  

  • 38. [A multicenter clinical study of nafate for treatment of hepatic fibrosis in patients with chronic liver diseases].
    Li Q; Zhang YJ; Shi GF; Bian L; An P; Lin BL; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Oct; 15(10):749-52. PubMed ID: 17963601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver extracts in therapy of diseases of the liver].
    LEMAIRE A; LOEPER J
    Mars Med; 1951; 88(7):348-52. PubMed ID: 14881766
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.